RxDoctor Payments Data

Marshall Tynes, DO

Family Medicine · Meridian, MSNPI 1063509719

Payments from drug & device makers

$2,541in general payments, 2019–2025

Across 155 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$670
  • AstraZeneca$342
  • Lilly USA, LLC$342
  • Amgen$252
  • Pfizer$232
  • Bayer$100
  • plus $603 from 16 others

What the payments were for

  • Food & beverage$2,535100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,541 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$213,526
Medicare patients
542
Services billed
2,619

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide114$122,271
FarxigaDapagliflozin Propanediol111$91,702
TrulicityDulaglutide34$48,639
LinzessLinaclotide44$43,261
EliquisApixaban51$40,667
JardianceEmpagliflozin36$32,835
XareltoRivaroxaban36$19,674
Bydureon BciseExenatide Microspheres17$17,243
JanuviaSitagliptin Phosphate13$14,512
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$12,769
Potassium Chloride336$6,080
Pantoprazole Sodium445$6,015
Incruse ElliptaUmeclidinium Bromide15$6,011
Valsartan338$5,519
SynthroidLevothyroxine Sodium65$5,243

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$67$122,271114 claims
AstraZenecaFarxiga$342$91,702111 claims
Lilly USA, LLCTrulicity$342$48,63934 claims
AbbVieLinzess, Synthroid$670$48,503109 claims
PfizerEliquis$232$40,66751 claims
Boehringer IngelheimJardiance$14$32,83536 claims
MerckJanuvia$28$14,51213 claims
GSKIncruse Ellipta$97$6,01115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Meridian

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →